Substance Abuse Treatment Prevention and Policy

Article	Citations
Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users	60
The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public hea	52
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada	35
Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre	32
Validity of self-reported substance use: research setting versus primary health care setting	30
‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America	30
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review	28
Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study	27
Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study	26
Examining prevalence and correlates of smoking opioids in British Columbia: opioids are more often smoked than injected	26
20 years of Portuguese drug policy - developments, challenges and the quest for human rights	23
Patient perspectives on depot buprenorphine treatment for opioid addiction – a qualitative interview study	21
Strategies to promote the implementation of Screening, Brief Intervention, and Referral to Treatment (SBIRT) in healthcare settings: a scoping review	21
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway	21
A double-edged sword of using opioids and COVID-19: a toxicological view	20
The changing alcohol drinking patterns among older adults show that women are closing the gender gap in more frequent drinking: the Tromsø study, 1994–2016	20
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs	19
A scoping review of factors that influence opioid overdose prevention for justice-involved populations	19
Implementation of tobacco control measures in the Gulf Cooperation Council countries, 2008–2020	19
Research led by people who use drugs: centering the expertise of lived experience	19
Missed opportunity for alcohol use disorder screening and management in primary health care facilities in northern rural Tanzania: a cross-sectional survey	18
Assessing the impact of a restrictive opioid prescribing law in West Virginia	18
Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review	18
Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada	18
Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients	17

Frequencies of emergency department use and hospitalization comparing patients with different types of substance or polysubstance-related disorders	17
Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia	17
The relationship between family intimacy and relapse tendency among people who use drugs: a moderated mediation model	16
Gender disparities in opioid treatment progress in methadone versus counseling	16
Drug Abstinence Self-Efficacy Scale (DASES): psychometric properties of the Farsi version	16
Prevalence and associated factors for alcohol use disorder among tuberculosis patients: a systematic review and meta-analysis study	15
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study	15
Digital interventions for substance use disorders in young people: rapid review	15
Social capital and chemsex initiation in young gay, bisexual, and other men who have sex with men: the pink carpet Y cohort study	14
“The DEA would come in and destroy you”: a qualitative study of fear and unintended consequences among opioid prescribers in WV	14
Resilience and related factors as predictors of relapse risk in patients with substance use disorder: a cross-sectional study	13
Differences in addiction and recovery gains according to gender – gender barriers and specific differences in overall strengths growth	13
Naloxone availability in independent community pharmacies in Georgia, 2019	12
A qualitative study exploring how young people perceive and experience substance use services in British Columbia, Canada	12
Associations between parental alcohol problems in childhood and adversities during childhood and later adulthood: a cross-sectional study of 28047 adults from the general population	12
The growth of recovery capital in clients of recovery residences in Florida, USA: a quantitative pilot study of changes in REC-CAP profile scores	12
Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA	12
Concerns among people who use opioids during the COVID-19 pandemic: a natural language processing analysis of social media posts	11
The effects of maternal alcohol consumption during pregnancy on adverse fetal outcomes among pregnant women attending antenatal care at public health facilities in Gondar town, Northwest Ethiopia: a p	11
Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder	11
A review of research-supported group treatments for drug use disorders	11
Cyber-ethnography of cannabis marketing on social media	10
Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators	10
Understanding injecting drug use in Afghanistan: A scoping review	10
Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes	10
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review	10
Various forms of alcohol use and their predictors among pregnant women in post conflict northern Uganda: a cross sectional study	10
Prevalence and correlates of substance use among school-going adolescents (11-18years) in eight Sub-Saharan Africa countries	10
Prevalence and correlates of non-daily and daily cannabis use among persons 15 years and older in South Africa: results of a national survey in 2017	10
Factors associated with substance use disorder treatment completion: a cross-sectional analysis of justice-involved adolescents	10
Qualitative assessment of patients’ perspectives and needs from community pharmacists in substance use disorder management	9
Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021	9
The association between methamphetamine use and number of sexual partners in men who have sex with men: a systematic review and meta-analysis	9
Perspectives of illicit marijuana growers and traders on commercial legalisation of marijuana in South Africa: considerations for policy formulation	9
Youth substance use service provider’s perspectives on use and service access in ontario: time to reframe the discourse	9
“They’re not doing enough.”: women’s experiences with opioids and naloxone in Toronto	9
Tobacco use, smoking identities and pathways into and out of smoking among young adults: a meta-ethnography	8
COVID 19—impact on substance use treatment utilization and provision in South Africa	8
The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence	8
Alcohol use and associated factors among adolescent boys and young men in Kampala, Uganda	8
The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men	8
Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: a repeated cross-sectional study from May 2020 to December 2020	8
“I can’t live like that”: the experience of caregiver stress of caring for a relative with substance use disorder	8
Relationships between consumption patterns, health beliefs, and subjective wellbeing in Chinese Baijiu consumers	8
Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy	8
Changes in opioid-related deaths following increased access to opioid substitution treatment	8
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020	8
The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya	7
Polysubstance use in a community sample of Black cisgender sexual minority men and transgender women in Chicago during initial COVID-19 pandemic peak	7
The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis	7

Effects of treatment status and life quality on anxiety in MMT patients	7
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment	7
Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals’ experiences	7
Becoming our young people’s case managers: caregivers’ experiences, needs, and ideas for improving opioid use treatments for young people using opioids	7
“That’s the whole thing about vaping, it’s custom tasty goodness”: a meta-ethnography of young adults’ perceptions and experiences of e-cigarette use	7
Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study	7
School-based harm reduction with adolescents: a pilot study	7
Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs	7
Alcohol and illicit drug use among young people living with HIV compared to their uninfected peers from the Kenyan coast: prevalence and risk indicators	7
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study	7
The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis	6
Examination of referral source and retention among women in residential substance use disorder treatment: a prospective follow-up study	6
Access to tablet injectable opioid agonist therapy in rural and smaller urban settings in British Columbia, Canada: a qualitative study	6
Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data	6
Drug dealing and drug use prevention – a qualitative interview study of authorities’ perspectives on two open drug scenes in Stockholm	6
Impact of the COVID-19 pandemic on alcohol or drug use symptoms and service need among youth: a cross-sectional sample from British Columbia, Canada	6
HIV testing and its associated factors among street-based female sex workers in Iran: results of a national rapid assessment and response survey	6
Navigating intersecting public health crises: a qualitative study of people with opioid use disorders' experiences during the COVID-19 pandemic	6
The impact of PSTD on service access among people who use drugs in Vancouver, Canada	6
“Students in public and private schools—which are at higher risk of drug use?”: a survey from Iran	6
Awareness and knowledge of the Good Samaritan Drug Overdose Act among people at risk of witnessing an overdose in British Columbia, Canada: a multi-methods cross sectional study	5
Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada	5
Youth cannabis use in Canada post-legalization: service providers’ perceptions, practices, and recommendations	5
Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado	5
Alcohol use disorders, beverage preferences and the influence of alcohol marketing: a preliminary study	5
“Sometimes you have to take the person and show them how”: adapting behavioral activation for peer recovery specialist-delivery to improve methadone treatment retention	5
Faculty, staff, and student perceptions of substance use disorder stigma in health profession training programs: a quantitative study	5
Evolution of policy for the treatment of substance use disorders in Qatar	5
Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors	5
Patterns, trends and determinants of medical opioid utilization in Canada 2005–2020: characterizing an era of intensive rise and fall	5
Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical mariju	5
How to prevent alcohol and illicit drug use among students in affluent areas: a qualitative study on motivation and attitudes towards prevention	5
Understanding the laps and relapse process: in-depth interviews with individual who use methamphetamine	5
Effectiveness of the world anti-doping agency's e-learning programme for anti-doping education on knowledge of, explicit and implicit attitudes towards, and likelihood of doping among Chinese college	5
A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service	5
The Alcohol Use Disorders Identification Test (AUDIT) in the Russian language - a systematic review of validation efforts and application challenges	5
Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition	5
Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program	4
A UK national study of prevalence and correlates of adopting or not adopting a recovery identity among individuals who have overcome a drug or alcohol problem	4
“I think everybody should take it if they’re doing drugs, doing heroin, or having sex for money”: a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an	4
Product variety and regulation avoidance in the sale of new tobacco products: findings from a point-of-sale survey in Indonesia	4
Equine-assisted services for individuals with substance use disorders: a scoping review	4
Perceived difficulty of getting help to reduce or abstain from substances among sexual and gender minority men who have sex with men (SGMSM) and use methamphetamine during the early period of the COVI	4
Variation in brief treatment for substance use disorder: a qualitative investigation of four federally qualified health centers with SBIRT services	4
Illicit drug use in university students in the UK and Ireland: a PRISMA-guided scoping review	4
Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020	4
Certificate-of-need laws and substance use treatment	4
Interdisciplinary collaboration in the treatment of alcohol use disorders in a general hospital department: a mixed-method study	4
Impact of an addiction medicine consult team intervention in a Canadian inner city hospital on acute care utilization: a pragmatic quasi-experimental study	4
Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway	4
Nicotine dependence and associated factors among persons who use electronic e-cigarettes in Malaysia - an online survey	4
Treatment barriers among young adults living with a substance use disorder in Tshwane, South Africa	4
Developing a novel treatment for patients with chronic pain and Opioid User Disorder	4
Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada	4
Developing and validating a measurement tool to self-report perceived barriers in substance use treatment: the substance use treatment barriers questionnaire (SUTBQ)	4
Healthcare seeking among Swedish patients in opioid substitution treatment – a mixed methods study on barriers and facilitators	4
Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community	4
The prospects for sustaining evidence-based responses to the US opioid epidemic: state leadership perspectives	4
Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017	4
The impact of the COVID-19 pandemic on access to supervised consumption programs	4
Alcohol outlets and alcohol consumption in changing environments: prevalence and changes over time	4
Contextual influences of illicit adolescent marijuana cultivation and trading in the Inqguza Hill local municipality of South Africa: implications for public health policy	4
Belief that addiction is a discrete category is a stronger correlate with stigma than the belief that addiction is biologically based	3
“2.5 g, I could do that before noon”: a qualitative study on people who use drugs’ perspectives on the impacts of British Columbia’s decriminalization of illegal drugs threshold limit	3
Investigating the factor structure of a translated recovery-orientation instrument in inpatient treatment for substance use disorder	3
Alcohol use during pregnancy in post-conflict northern Uganda: pregnant women’s experiences and provider perceptions	3
Patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study	3
Factors influencing the provision of care for Inuit in a mainstream residential addiction rehabilitation centre in Southern Canada, an instrumental case study into cultural safety	3
Tobacco harm reduction in Afghanistan: a recipe for improving smokers’ health	3
Proportion and reasons for loss to follow-up in a cohort study of people who inject drugs to measure HIV and HCV incidence in Kerman, Iran	3
The relationship between severity of drug problems and perceived interdependence of drug use and sexual intercourse among adult males in drug addiction rehabilitation centers in Japan	3
The association of workplace health education with smoking-related behaviour and unequal gains by job position in China: ABWMC programme findings	3
Assessing public behavioral health services data: a mixed method analysis	3
A review of social media platform policies that address cannabis promotion, marketing and sales	3
Are former heavy drinkers in the UK less likely to identify as being in recovery compared to those in the USA? A pilot test	3
Technology-based interventions for tobacco smoking prevention and treatment: a 20-year bibliometric analysis (2003–2022)	3
Evaluation of post-discharge engagement for emergency department patients with opioid use history who received telehealth recovery coaching services	3
Client satisfaction to methadone maintenance treatment program in Myanmar	3
The International Center for Alcohol Policies (ICAP) book series: a key resource globally for alcohol industry political strategies	3
Tailoring dissemination of evidence to preferences of tobacco control partners: results from an academic-community partnership	3

Mandatory treatment for methamphetamine use in Australia	3
Assessing the impact of Indiana legislation on opioid-based doctor shopping among Medicaid-enrolled pregnant women: a regression analysis	3
Profiles of quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes among patients with substance-related disorders	3
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain	3
A qualitative exploration of daily path and daily routine among people in Ukraine who inject drugs to understand associated harms	3
Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia	3
Commercial and public payer opioid analgesic prescribing policies: a case study	3
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder	3
Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017	3